02:00 Thu 27 Feb 2020
BATM Advanced Comm - BATM Develops Diagnostics Kit for COVID-19
LEI: 213800FLQUB9J289RU66
("BATM" or "the Group")
BATM Develops Diagnostics Kit for COVID-19
BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that its Bio-Medical division has successfully developed a new diagnostics kit to detect COVID-19. Additionally, this kit has undergone testing by several central laboratories and hospitals that have now verified its ability to diagnose COVID-19.
The Group has commenced production of the kit at its Adaltis facility in
In addition, COVID-19 will be included within the Ador suite of testing kits as part of its travel panels. Laboratory bench tests are expected to commence imminently.
Dr
"We believe that the strategy we adopted in our Bio-Medical division is proving to be correct, especially in light of the current COVID-19 outbreak. We are able now to quickly provide diagnostic kits for any new pathogen that appears.
"Furthermore, we have already received extremely positive feedback and significant interest from several leading medical institutions that have started testing the first panel of Ador's NATlab solution and adding COVID-19 will greatly strengthen its appeal and value."
Enquiries:
|
|
Dr |
+972 9866 2525 |
|
|
|
|
Shore Capital |
|
|
+44 20 7408 4050 |
|
|
|
|
Harry Chathli, |
+44 20 7618 9100 |
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE